DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer


Aberrant expression of DJ-1 has been proven to be associated with tumorigenesis in many carcinomas. However, its role in pancreatic cancer is unknown. The aims of this study were to investigate whether the serum DJ-1 might be a potential biomarker for pancreatic cancer and to determine the biologic function of DJ-1 expression in gemcitabine-induced… (More)
DOI: 10.1007/s00432-012-1205-3


8 Figures and Tables